[go: up one dir, main page]

NO302231B1 - Fenylsubstituerte alkylkarboksylsyreguanidider som bærer perfluoralkylgrupper, deres anvendelse til fremstilling av medikament eller diagnostikum samt medikamenter inneholdende disse - Google Patents

Fenylsubstituerte alkylkarboksylsyreguanidider som bærer perfluoralkylgrupper, deres anvendelse til fremstilling av medikament eller diagnostikum samt medikamenter inneholdende disse

Info

Publication number
NO302231B1
NO302231B1 NO950258A NO950258A NO302231B1 NO 302231 B1 NO302231 B1 NO 302231B1 NO 950258 A NO950258 A NO 950258A NO 950258 A NO950258 A NO 950258A NO 302231 B1 NO302231 B1 NO 302231B1
Authority
NO
Norway
Prior art keywords
phenyl
diagnostics
drug
manufacture
carboxylic acid
Prior art date
Application number
NO950258A
Other languages
English (en)
Norwegian (no)
Other versions
NO950258L (no
NO950258D0 (no
Inventor
Jan-Robert Schwark
Heinz-Werner Kleemann
Hans-Jochen Lang
Andreas Weichert
Wolfgang Scholz
Udo Albus
Original Assignee
Hoechst Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DE4402057A external-priority patent/DE4402057A1/de
Priority claimed from DE4413615A external-priority patent/DE4413615A1/de
Application filed by Hoechst Ag filed Critical Hoechst Ag
Publication of NO950258D0 publication Critical patent/NO950258D0/no
Publication of NO950258L publication Critical patent/NO950258L/no
Publication of NO302231B1 publication Critical patent/NO302231B1/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D241/00—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
    • C07D241/02—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings
    • C07D241/10—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
    • C07D241/14—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D241/24—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D241/26—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals with nitrogen atoms directly attached to ring carbon atoms
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N1/00—Preservation of bodies of humans or animals, or parts thereof
    • A01N1/10—Preservation of living parts
    • A01N1/12—Chemical aspects of preservation
    • A01N1/122—Preservation or perfusion media
    • A01N1/126—Physiologically active agents, e.g. antioxidants or nutrients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B10/00—Instruments for taking body samples for diagnostic purposes; Other methods or instruments for diagnosis, e.g. for vaccination diagnosis, sex determination or ovulation-period determination; Throat striking implements
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C279/00—Derivatives of guanidine, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups
    • C07C279/20—Derivatives of guanidine, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups containing any of the groups, X being a hetero atom, Y being any atom, e.g. acylguanidines
    • C07C279/22—Y being a hydrogen or a carbon atom, e.g. benzoylguanidines

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cardiology (AREA)
  • Biomedical Technology (AREA)
  • Dentistry (AREA)
  • Pathology (AREA)
  • Environmental Sciences (AREA)
  • Medical Informatics (AREA)
  • Molecular Biology (AREA)
  • Surgery (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
NO950258A 1994-01-25 1995-01-24 Fenylsubstituerte alkylkarboksylsyreguanidider som bærer perfluoralkylgrupper, deres anvendelse til fremstilling av medikament eller diagnostikum samt medikamenter inneholdende disse NO302231B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE4402057A DE4402057A1 (de) 1994-01-25 1994-01-25 Perfluoralkylgruppen tragende phenyl-substituierte Alkylcarbonsäure-guanidine, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltendes Medikament
DE4413615A DE4413615A1 (de) 1994-04-19 1994-04-19 Perfluoralkylgruppen tragende phenyl-substituierte Alkylcarbonsäure-guanidine, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltendes Medikament

Publications (3)

Publication Number Publication Date
NO950258D0 NO950258D0 (no) 1995-01-24
NO950258L NO950258L (no) 1995-07-26
NO302231B1 true NO302231B1 (no) 1998-02-09

Family

ID=25933249

Family Applications (1)

Application Number Title Priority Date Filing Date
NO950258A NO302231B1 (no) 1994-01-25 1995-01-24 Fenylsubstituerte alkylkarboksylsyreguanidider som bærer perfluoralkylgrupper, deres anvendelse til fremstilling av medikament eller diagnostikum samt medikamenter inneholdende disse

Country Status (15)

Country Link
US (1) US5567734A (hu)
EP (1) EP0666252B1 (hu)
JP (1) JP3718250B2 (hu)
AT (1) ATE225332T1 (hu)
AU (1) AU683328B2 (hu)
CA (1) CA2140989C (hu)
DE (1) DE59510395D1 (hu)
DK (1) DK0666252T3 (hu)
ES (1) ES2184770T3 (hu)
FI (1) FI950305A (hu)
HU (1) HU217617B (hu)
NO (1) NO302231B1 (hu)
NZ (1) NZ270370A (hu)
PT (1) PT666252E (hu)
TW (1) TW415937B (hu)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4412334A1 (de) * 1994-04-11 1995-10-19 Hoechst Ag Substituierte N-Heteroaroylguanidine, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltendes Medikament
EP0765867A1 (de) * 1995-09-27 1997-04-02 Hoechst Aktiengesellschaft Substituierte Benzoylguanidine, Verfahren zu ihrer Herstellung, ihre Verwendung als Antiarrhytmika oder Diagnostikum sowie sie enthaltendes Medikament
DE19540995A1 (de) * 1995-11-03 1997-05-07 Hoechst Ag Substituierte Sulfonimidamide, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltendes Medikament
DE19542306A1 (de) * 1995-11-14 1997-05-15 Hoechst Ag Sulfonylamino-substituierte Benzoylguanidine, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltendes Medikament
PL316439A1 (en) * 1995-11-20 1997-05-26 Hoechst Ag Novel substituted derivatives of benzoyloguanidine, method of obtaining them, their application in production of pharmaceutic and diagnostic agents and pharmaceutic agent as such
DE19546736A1 (de) * 1995-12-14 1997-06-19 Hoechst Ag Substituierte Chromanylsulfonyl(thio)harnstoffe, Verfahren zu ihrer Herstellung und ihre Verwendung zur Herstellung pharmazeutischer Präparate
DE19605610A1 (de) * 1996-02-15 1997-08-21 Hoechst Ag Substituierte Thiophenylalkenylcarbonsäureguanidide, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltendes Medikament
US6429481B1 (en) * 1997-11-14 2002-08-06 Fairchild Semiconductor Corporation Field effect transistor and method of its manufacture
WO2000044707A1 (fr) * 1999-01-27 2000-08-03 Sumitomo Pharmaceuticals Company, Limited Nouveaux derives de guanidine substitues et leur procede de preparation
JP5030587B2 (ja) * 2003-06-26 2012-09-19 バイオトロン・リミテッド 抗ウイルスアシルグアニジン化合物および方法
US20070099968A1 (en) * 2004-06-26 2007-05-03 Biotron Limited Antiviral compounds and methods
TW200808705A (en) * 2006-06-15 2008-02-16 Sanofi Aventis Aryl- and heteroaryl-ethyl-acylguanidine derivatives, their preparation and their application in therapeutics

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3780027A (en) * 1970-04-29 1973-12-18 Merck & Co Inc Anthranilic acid derivatives
DE2931735A1 (de) * 1979-08-04 1981-02-19 Beiersdorf Ag Neue substituierte phenylacetylguanidine und verfahren zu ihrer herstellung
EP0087218B1 (en) * 1982-02-10 1985-05-02 Beecham Group Plc Guanidine derivatives
US4544670A (en) * 1982-08-24 1985-10-01 William H. Rorer, Inc. Method of treating coccidiosis with acyl guanidines
DE3929582A1 (de) * 1989-09-06 1991-03-07 Hoechst Ag Benzoylguanidine, verfahren zu ihrer herstellung, ihre verwendung als medikament sowie sie enthaltendes medikament
CZ284456B6 (cs) * 1992-02-15 1998-12-16 Hoechst Aktiengesellschaft Aminosubstituované benzoylguanidiny, způsob jejich přípravy, jejich použití jako léčiv a léčivo, které je obsahuje
DE4318658A1 (de) * 1993-06-04 1994-12-08 Hoechst Ag Substituierte Benzoylguanidine, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltendes Medikament

Also Published As

Publication number Publication date
NO950258L (no) 1995-07-26
CA2140989A1 (en) 1995-07-26
HU217617B (hu) 2000-03-28
DK0666252T3 (da) 2003-01-27
NO950258D0 (no) 1995-01-24
NZ270370A (en) 1995-09-26
HUT71413A (en) 1995-11-28
FI950305A0 (fi) 1995-01-24
HU9500211D0 (en) 1995-05-29
ATE225332T1 (de) 2002-10-15
FI950305A (fi) 1995-07-26
AU683328B2 (en) 1997-11-06
US5567734A (en) 1996-10-22
TW415937B (en) 2000-12-21
JP3718250B2 (ja) 2005-11-24
DE59510395D1 (de) 2002-11-07
JPH07224022A (ja) 1995-08-22
CA2140989C (en) 2006-09-19
EP0666252A1 (de) 1995-08-09
AU1135395A (en) 1995-08-03
PT666252E (pt) 2003-02-28
EP0666252B1 (de) 2002-10-02
ES2184770T3 (es) 2003-04-16

Similar Documents

Publication Publication Date Title
NO302231B1 (no) Fenylsubstituerte alkylkarboksylsyreguanidider som bærer perfluoralkylgrupper, deres anvendelse til fremstilling av medikament eller diagnostikum samt medikamenter inneholdende disse
DK0640069T3 (da) Fluoralkenylforbindelser og deres anvendelse som midler til bekæmpelse af skadelige organismer
NO910711L (no) Middel bestaaende av cavitat- eller clathrat- dannende vert/gjest-komplekser som kontrastmiddel.
FI953003A (fi) Perfluorialkyyliryhmillä varustettuja fenyylisubstituoituja alkenyylikarboksyylihappoguanididejä, menetelmä niiden valmistamiseksi, niiden käyttö lääkeaineena tai diagnostisena aineena sekä niitä sisältävä lääkeaine
DE69329036D1 (de) Formfaktor 2,5 zoll plattenantrieb niedriger höhe
DK164163C (da) Analogifremgangsmaade til fremstilling af 4-oxo-4h-oe1aa-benzopyran-8-yl-alkansyrer eller estere eller dialkylaminoalkylamider deraf eller alkalimetalsalte deraf samt 4-oxo-4h-oe1aa-benzopyran-8-yl-alkannitriler til anvendelse som mellemprodukter
DK164483C (da) Fremgangsmaade til opbevaring af phospholipid liposomer
ES476682A1 (es) Un procedimiento para la preparacion de nuevos dericados de 1-aza-biciclo (2,2,2)octano, utiles como psicotrupos.
ATE112320T1 (de) Sekretormutante von escherichia coli.
DK444982A (da) Substituerede hydroxymalonsyrediamider, fremgangsmaade til fremstilling deraf samt deres anvendelse som skadedyrsbekaempende midler
DK0525506T3 (da) Fremgangsmåde til alfa-monoalkylering af arylacetonitriler, arylacetoestere og aryleddikesyrer
AR247327A1 (es) Una composicion herbicida
ES535996A0 (es) Procedimiento para preparar acido (d)-2-(6-metoxi-2-naftil)-propionico y sales farmaceuticamente aceptables del mismo
DE68919709D1 (de) Trisubstituierte benzoesäure-zwischenverbindungen.
PH27224A (en) Benzoic acid derivatives
ES523745A0 (es) Procedimiento para la preparacion de nuevos derivados de acidos apovincaminicos racemicos y opticamente activos, y de sus sales de adicion acidas
SU568834A1 (ru) Опорна перегородка дл труб теплообменного аппарата
DK498484A (da) Halogenbenzylestere, insekticide midler med indhold heraf samt fremgangsmaade til fremstilling heraf.
FI880410A0 (fi) 2-(2,2-difluorocyklopropyl)-alkyl -estrar, foerfarande foer deras framstaellning och deras anvaendning som bekaempningsmedel mot skadeinsekter och kvalster.
FI934252A0 (fi) 1,5,6,7-tetrahydro-4h-indazol-4-oner innehaollande laekemedel, nya 1,5,6,7-tetrahydro-4h-indazol-4-oner och foerfarande foer deras framstaellning
FR2163875A5 (en) 3-benzoylphenyl acetic and 2-(3-benzoyl phenyl) - propionic acids prepn - for use as anti-inflammatories
FR2202873A2 (en) 3-benzoylphenyl acetic and 2-(3-benzoyl phenyl) - propionic acids prepn - for use as anti-inflammatories
NO890233D0 (no) Reguleringssystemer for biologiske prosesser som danner viskoese dyrkingsmedia.
DK597487A (da) Hyaluronsyre-tungmetalsalte til anvendelse som mikrobielle midler
ES271218Y (es) Mando impulsor de liquidos, para juguetes.

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees